Form 4: Guardant Health Executive Craig Eagle Reports Stock Transactions
SEC Form 4 Filing
Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting of restricted stock units and subsequent share sales to cover tax obligations.
Summary
- Craig Eagle, the Chief Medical Officer of Guardant Health, Inc., reported transactions involving the company's stock on April 1, 2024.
- These transactions involved the vesting of 1,714 restricted stock units (RSUs) and the subsequent disposal of 621 shares to cover tax withholding obligations.
- Following these transactions, Eagle directly owns 11,452 shares of Guardant Health common stock and 17,142 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of grant for the restricted stock unit award vesting over four years. |
| October 1, 2023 | 25% of the restricted stock units vested. |
| April 1, 2024 | Date of the reported transactions: vesting of RSUs and share disposal for tax obligations. |
| April 2, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.